Abstract
The aim of this work was to study the solubility in supercritical CO2 of the hydrated phase of three model drugs, namely theophylline, carbamazepine, and diclofenac sodium, in comparison with the respective anhydrous form. Possible solid-state modifications, stemming from the interaction with supercritical CO2, were investigated by differential scanning calorimetry, thermogravimetric analysis, hot stage microscopy, Fourier Transform infrared spectroscopy and Karl-Fischer titrimetry. It was found that all three pharmaceutical hydrates exhibited higher solubility in supercritical CO2 than the relevant anhydrous phases. In the case of theophylline monohydrate, the instability of the crystal phase at the experimental temperature adopted has been evidenced. Diclofenac sodium tetrahydrate represents a peculiar case of chemical interaction with the acid supercritical fluid, mediated by crystal water.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. J. Aguiar, J. Krc, A. W. Kinkel and C. Samyn, J. Pharm. Sci., 56 (1967) 847.
S. R. Vippagunta, H. G. Brittain and D. J. W. Grant, Adv. Drug Delivery Rev., 48 (2001) 3.
S. Datta and D. J. W. Grant, Nature Rev. Drug Discovery, 3 (2004) 42.
D. J. W. Grant and S. R. Byrn, Adv. Drug Delivery Rev., 56 (2004) 237.
H. G. Brittain and D. J. W. Grant, in H. G. Brittain (Ed.) Polymorphism in Pharmaceutical Solids, Marcel Dekker, New York 1999, p. 279.
J. T. Carstensen, Advanced Pharmaceutical Solids, Marcel Dekker, New York 2001, p. 177.
R. K. Khankari and D. J. W. Grant, Thermochim. Acta, 248 (1995) 61.
M. Perrut, S. T. P. Pharma Sci., 13 (2003) 83.
R. Bettini, L. Bonassi, V. Castoro, A. Rossi, L. Zema, A. Gazzaniga and F. Giordano, Eur. J. Pharm. Sci., 13 (2001) 281.
R. Bettini, M. Zampieri, A. Martini, P. Fumagalli, A. Rossi and F. Giordano, Proceed. AAPS Annual Meeting (2002) #T2327.
H. H. Y. Tong, B. Y. Shekunov, P. York and A. H. L. Chow, Pharm. Res., 18 (2001) 252.
J. Han and R. Suryanarayanan, Pharm. Dev. Tech., 3 (1998) 587.
Y. Li, J. Han, G. G. Z. Zhang, D. W. J. Grant and R. Suryanarayanan, Pharm. Dev. Tech., 5 (2000), 257.
R. Bettini, A. Rossi, E. Lavezzini, I. Pasquali and F. Giordano, J. Therm. Anal. Cal., 73 (2003) 487.
USP 27, United States Pharmcopoeial Convention, Inc. Rockville, MD, USA, 2004, p. 1812.
R. J. Behme and D. Brooke, J. Pharm. Sci., 80 (1991) 986.
M. D. A. Saldana, R. S. Mohamed, M. G. Baer and P. Mazzafera, J. Agric. Food Chem., 47 (1999) 3804.
L. E. McMahon, T. P. Timmins, A. C. Williams and P. York, J. Pharm. Sci., 85 (1996) 1064.
R. Bettini, F. Giordano, C. Donini, G. Massimo, P. L. Catellani and P. Colombo, S. T. P. Pharma Sci., 10 (2000) 335.
European Pharmacopoeia 4th edition, Directorate for the Quality of Medicines of the Council of Europe, Strasbourg, F, 2001, p. 1032.
D. H. Williams and I. Fleming, Spectroscopic methods in organic chemistry, McGraw-Hill Book Co. London 1996, p. 57.
T. Umeda, N. Ohinishi, T. Yokaoyama, K. Kuroda, T. Kuroda, E. Totsumi and Y. Matsuda, Yakugaku Zasshi, 104 (1984) 786.
C. H. Gu and D. J. W. Grant, J. Pharm. Sci., 90 (2001) 1277.
K. R. Morris, in H. G. Brittain (Ed.) Polymorphism in Pharmaceutical Solids, Marcel Dekker, New York 1999, p. 130.
D. J. W. Grant and T. Higuchi, Solubility Behavior of Organic Compound, Wiley & Sons, New York, 1990, pp. 38–39.
R. Wiebe and V. L. Gaddy, J. Am. Chem. Soc., 61 (1939) 315.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bettini, R., Bertolini, G., Frigo, E. et al. Interaction of pharmaceutical hydrates with supercritical CO2 . Journal of Thermal Analysis and Calorimetry 77, 625–638 (2004). https://doi.org/10.1023/B:JTAN.0000038999.29199.04
Issue Date:
DOI: https://doi.org/10.1023/B:JTAN.0000038999.29199.04